跳至主要内容
临床试验/NCT04600232
NCT04600232Unknown不适用

Clinical Utility of TB-LAM in the Diagnosis of Active TB in Hospitalized HIV-infected Patients

Shanghai Public Health Clinical Center0 个研究点目标入组 400 人开始时间: 2020年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
400
主要终点
Specificity against microbiological reference standard

研究概览

简要总结

Tuberculosis (TB) is still the leading cause of death in HIV-infected patients. Early diagnosis of TB substantially improves the survival of HIV-infected patients. Urine based detection of lipoarabinomannan (LAM) provides promising methods for quick diagnosis of TB in HIV-infected patients. However, the sensitivity and specificity of TB-LAM is still not well established, especially in area where non-tuberculosis mycobacterium is also prevalence. Here we aimed to evaluate the clinical utility of TB-LAM in diagnosis of active TB in hospitalized HIV-infected patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Hospitalized HIV-infected patients.
  • Willing to participate into the study.

排除标准

  • Already diagnosed with active TB
  • Received any anti-tuberculosis drugs and/or quinolone for more than 7 days.

结局指标

主要结局

Specificity against microbiological reference standard

时间窗: 2 months

1-Number of TB-LAM negative/Number of negative by culture or Gene Xpert or smear

Sensitivity against microbiological reference standard

时间窗: 2 months

Number of TB-LAM positive/Number of positive by culture or Gene Xpert

次要结局

  • Sensitivity against composite reference standard(2 months)
  • Specificity against composite reference standard(2 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jun Chen

Shanghai Public Health Clinical Center

Shanghai Public Health Clinical Center

相似试验